Efficacy and Treatment Related Toxicity Study of a New Regimen for Lymphoma
Condition(s):Non-Hodgkin’s Lymphoma; Hodgkin’s DiseaseLast Updated:January 8, 2016Completed
Hide Studies Not Open or Pending
Condition(s):Non-Hodgkin’s Lymphoma; Hodgkin’s DiseaseLast Updated:January 8, 2016Completed
Condition(s):LymphomaLast Updated:July 26, 2013Completed
Condition(s):Human Epidermal Growth Factor 2 Negative Carcinoma of BreastLast Updated:February 26, 2019Not yet recruiting
Condition(s):Stage Ib Lung CarcinomaLast Updated:November 2, 2014Unknown status
Condition(s):Lung CancerLast Updated:February 15, 2013Completed
Condition(s):Non-small Cell Lung CancerLast Updated:March 9, 2010Unknown status
Condition(s):Breast CancerLast Updated:May 9, 2008Unknown status
Condition(s):Breast CancerLast Updated:March 14, 2013Completed
Condition(s):Lung CancerLast Updated:August 2, 2013Completed
Condition(s):Breast Cancer; Stage II Breast Cancer; Stage III Breast CancerLast Updated:January 15, 2019Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.